Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfredi Rizzo

Showing results (81-90 of 522) with videos related to

Pageof 53
Sort By:
Journal of Diabetes and Its Complications|February 6, 2026
Extending beyond established cardiometabolic benefits of empagliflozin in type 2 diabetes: the evolving paradigm of glycemic variabilityDimitrios Patoulias, Emir Muzurović, Viviana Maggio, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Clinical benefits of ezetimibe use: is absence of proof, proof of absence?Ioanna Gouni-Berthold, Dimitri P Mikhailidis, Manfredi Rizzo
Journal of Diabetes and Its Complications|October 1, 2024
Monitoring the liver as a part of the cardio-renal-metabolic continuum - What is cooking and burning with non-invasive tests and treatment options?Špela Volčanšek, Andrej Janež, Manfredi Rizzo, et al.
Journal of Diabetes and Its Complications|April 27, 2025
GLP-1 receptor agonists and MASLD in diabetes: A promising path?Grazia Pennisi, Salvatore Petta, Viviana Maggio, et al.
Frontiers in Clinical Diabetes and Healthcare|January 23, 2025
Altered kidney function in fatty liver disease: confronting the "MAFLD-renal syndrome"Suleiman Al Ashi, Ali A Rizvi, Manfredi Rizzo
Journal of Diabetes and Its Complications|March 29, 2025
Lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathyGeorgia Anastasiou, Viviana Maggio, Manfredi Rizzo, et al.
International Journal of Molecular Sciences|September 28, 2021
Metabolic Syndrome: From Molecular Mechanisms to Novel TherapiesAli Abbas Rizvi, Anca Pantea Stoian, Manfredi Rizzo
Metabolism: Clinical and Experimental|August 1, 2021
Incretin-based therapies in 2021 - Current status and perspectives for the futureManfredi Rizzo, Michael A Nauck, Christos S Mantzoros
Journal of Diabetes and Its Complications|November 10, 2024
Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?Dimitrios Pantazopoulos, Evanthia Gouveri, Manfredi Rizzo, et al.
Advances in Therapy|May 3, 2022
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative ReviewMojca Jensterle, Manfredi Rizzo, Martin Haluzík, et al.
Pageof 53

Showing results (81-90 of 522) with videos related to

Sort By:
Pageof 53
Journal of Diabetes and Its Complications|February 6, 2026
Extending beyond established cardiometabolic benefits of empagliflozin in type 2 diabetes: the evolving paradigm of glycemic variabilityDimitrios Patoulias, Emir Muzurović, Viviana Maggio, et al.
Expert Opinion on Pharmacotherapy|September 6, 2012
Clinical benefits of ezetimibe use: is absence of proof, proof of absence?Ioanna Gouni-Berthold, Dimitri P Mikhailidis, Manfredi Rizzo
Journal of Diabetes and Its Complications|October 1, 2024
Monitoring the liver as a part of the cardio-renal-metabolic continuum - What is cooking and burning with non-invasive tests and treatment options?Špela Volčanšek, Andrej Janež, Manfredi Rizzo, et al.
Journal of Diabetes and Its Complications|April 27, 2025
GLP-1 receptor agonists and MASLD in diabetes: A promising path?Grazia Pennisi, Salvatore Petta, Viviana Maggio, et al.
Frontiers in Clinical Diabetes and Healthcare|January 23, 2025
Altered kidney function in fatty liver disease: confronting the "MAFLD-renal syndrome"Suleiman Al Ashi, Ali A Rizvi, Manfredi Rizzo
Journal of Diabetes and Its Complications|March 29, 2025
Lipoprotein-associated phospholipase A2 and diabetic peripheral neuropathyGeorgia Anastasiou, Viviana Maggio, Manfredi Rizzo, et al.
International Journal of Molecular Sciences|September 28, 2021
Metabolic Syndrome: From Molecular Mechanisms to Novel TherapiesAli Abbas Rizvi, Anca Pantea Stoian, Manfredi Rizzo
Metabolism: Clinical and Experimental|August 1, 2021
Incretin-based therapies in 2021 - Current status and perspectives for the futureManfredi Rizzo, Michael A Nauck, Christos S Mantzoros
Journal of Diabetes and Its Complications|November 10, 2024
Cilostazol for the treatment of distal symmetrical polyneuropathy in diabetes mellitus: Where do we stand?Dimitrios Pantazopoulos, Evanthia Gouveri, Manfredi Rizzo, et al.
Advances in Therapy|May 3, 2022
Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative ReviewMojca Jensterle, Manfredi Rizzo, Martin Haluzík, et al.
Pageof 53